Interleukin‐17–producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers

Abstract

Objective To identify interleukin‐17 (IL‐17)–producing T cells from patients with juvenile idiopathic arthritis (JIA), and investigate their cytokine production, migratory capacity, and relationship to Treg cells at sites of inflammation, as well as to test the hypothesis that IL‐17+ T cell numbers correlate with clinical phenotype in childhood arthritis. Methods Flow cytometry was used to analyze the phenotype, cytokine production, and chemokine receptor expression of IL‐17–producing T cells in peripheral blood and synovial fluid mononuclear cells from 36 children with JIA, in parallel with analysis of forkhead box P3 (FoxP3)–positive Treg cells. Migration of IL‐17+ T cells toward CCL20 was assessed by a Transwell assay. Synovial tissue was analyzed by immunohistochemistry for IL‐17 and IL‐22. Results IL‐17+ T cells were enriched in the joints of children with JIA as compared with the blood of JIA patients ( P = 0.0001) and controls ( P = 0.018) and were demonstrated in synovial tissue. IL‐17+ T cell numbers were higher in patients with extended oligoarthritis, the more severe subtype of JIA, as compared with patients with persistent oligoarthritis, the milder subtype ( P = 0.046). Within the joint, there was an inverse relationship between IL‐17+ T cells and FoxP3+ Treg cells (r = 0.61, P = 0.016). IL‐17+,CD4+ T cells were uniformly CCR6+ and migrated toward CCL20, but synovial IL‐17+ T cells had variable CCR4 expression. A proportion of IL‐17+ synovial T cells produced IL‐22 and interferon‐γ. Conclusion This study is the first to define the frequency and characteristics of “Th17” cells in JIA. We suggest that these highly proinflammatory cells contribute to joint pathology, as indicated by relationships with clinical phenotypes, and that the balance between IL‐17+ T cells and Treg cells may be critical to outcome.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 52

1. 1.

   Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348-57.

   Not in our library

2. 2.

   Dolhain RJ, van der Heiden AN, ter Haar NT, Breedveld FC, Miltenburg AM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 1996;39:1961-9.

   Not in our library10.1002/art.1780391204

3. 3.

   Wedderburn LR, Robinson N, Patel A, Varsani H, Woo P. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum. 2000;43:765-74.

   Not in our library10.1002/1529-0131(200004)43:4<765::aid-anr7>3.0.co;2-b

4. 4.

   Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-β induces development of the TH17 lineage. Nature. 2006;441:231-4.

   Not in our library10.1038/nature04754

5. 5.

   Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol. 2006;18:349-56.

   Not in our library10.1016/j.coi.2006.03.017

6. 6.

   Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006;24:677-88.

   Not in our library10.1016/j.immuni.2006.06.002

7. 7.

   Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133-41.

   Not in our library10.1038/ni1261

8. 8.

   Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24:179-89.

   Not in our library10.1016/j.immuni.2006.01.001

9. 9.

   Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121-33.

   Not in our library10.1016/j.cell.2006.07.035

10. 10.

    Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003;171:6173-7.

    Not in our library10.4049/jimmunol.171.11.6173

11. 11.

    Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201:233-40.

    Not in our library10.1084/jem.20041257

12. 12.

    Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235-8.

    Not in our library10.1038/nature04753

13. 13.

    Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007;8:942-9.

    Not in our library10.1038/ni1496

14. 14.

    Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007;8:950-7.

    Not in our library10.1038/ni1497

15. 15.

    Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999;103:1345-52.

    Not in our library10.1172/jci5703

16. 16.

    Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human interleukin-17: a T cell–derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999;42:963-70.

    Not in our library10.1002/1529-0131(199905)42:5<963::aid-anr15>3.0.co;2-e

17. 17.

    De Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis. 2007;66:589-98.

    Not in our library10.1136/ard.2006.061853

18. 18.

    Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages. J Immunol. 1998;160:3513-21.

    Not in our library

19. 19.

    Chabaud M, Fossiez F, Taupin JL, Miossec P. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol. 1998;161:409-14.

    Not in our library

20. 20.

    Katz Y, Nadiv O, Beer Y. Interleukin-17 enhances tumor necrosis factor a–induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a “fine-tuning cytokine” in inflammation processes. Arthritis Rheum. 2001;44:2176-84.

    Not in our library10.1002/1529-0131(200109)44:9<2176::aid-art371>3.0.co;2-4

21. 21.

    Varsani H, Patel A, van Kooyk Y, Woo P, Wedderburn LR. Synovial dendritic cells in juvenile idiopathic arthritis (JIA) express receptor activator of NF-κB (RANK). Rheumatology (Oxford). 2003;42:583-90.

    Not in our library

22. 22.

    Masi L, Simonini G, Piscitelli E, Del Monte F, Giani T, Cimaz R, et al. Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury? J Rheumatol. 2004;31:986-91.

    Not in our library

23. 23.

    Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 2000;43:250-8.

    Not in our library10.1002/1529-0131(200002)43:2<250::aid-anr3>3.0.co;2-p

24. 24.

    Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum. 2001;44:1003-12.

    Not in our library10.1002/1529-0131(200105)44:5<1003::aid-anr179>3.0.co;2-#

25. 25.

    Chabaud M, Garnero P, Dayer JM, Guerne PA, Fossiez F, Miossec P. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine. 2000;12:1092-9.

    Not in our library10.1006/cyto.2000.0681

26. 26.

    Chabaud M, Lubberts E, Joosten L, van den Berg W, Miossec P. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res. 2001;3:168-77.

    Not in our library10.1186/ar294

27. 27.

    Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007;8:639-46.

    Not in our library10.1038/ni1467

28. 28.

    Aarvak T, Chabaud M, Kallberg E, Miossec P, Natvig JB. Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium. Scand J Immunol. 1999;50:1-9.

    Not in our library10.1046/j.1365-3083.1999.00581.x

29. 29.

    Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol. 2000;165:6107-15.

    Not in our library10.4049/jimmunol.165.11.6107

30. 30.

    Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390-2.

    Not in our library

31. 31.

    De Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol. 2004;172:6435-43.

    Not in our library10.4049/jimmunol.172.10.6435

32. 32.

    Ruprecht CR, Gattorno M, Ferlito F, Gregorio A, Martini A, Lanzavecchia A, et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med. 2005;201:1793-803.

    Not in our library10.1084/jem.20050085

33. 33.

    Pharoah DS, Varsani H, Tatham RW, Newton KR, de Jager W, Prakken BJ, et al. Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells. Arthritis Res Ther. 2006;8:R50-60.

    Not in our library10.1186/ar1913

34. 34.

    Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells. J Exp Med. 2001;194:847-53.

    Not in our library10.1084/jem.194.6.847

35. 35.

    Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med. 2007;13:711-8.

    Not in our library10.1038/nm1585

36. 36.

    Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006;203:2271-9.

    Not in our library10.1084/jem.20061308

37. 37.

    Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445:648-51.

    Not in our library10.1038/nature05505

38. 38.

    Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, Ueki K, et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 2005;52:1037-46.

    Not in our library10.1002/art.20965

39. 39.

    Feldmann M, Brennan FM, Maini RN. The role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397-440.

    Not in our library10.1146/annurev.immunol.14.1.397

40. 40.

    Rooney M, Varsani H, Martin K, Lombard PR, Dayer JM, Woo P. Tumour necrosis factor α and its soluble receptors in juvenile chronic arthritis. Rheumatology (Oxford). 2000;39:432-8.

    Not in our library10.1093/rheumatology/39.4.432

41. 41.

    Koenders MI, Lubberts E, van de Loo FA, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, et al. Interleukin-17 acts independently of TNF-α under arthritic conditions. J Immunol. 2006;176:6262-9.

    Not in our library10.4049/jimmunol.176.10.6262

42. 42.

    Asquith DL, McInnes IB. Emerging cytokine targets in rheumatoid arthritis. Curr Opin Rheumatol. 2007;19:246-51.

    Not in our library10.1097/bor.0b013e3280eec78c

43. 43.

    Miossec P. Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified. Arthritis Rheum. 2007;56:2111-5.

    Not in our library10.1002/art.22733

44. 44.

    Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, et al. Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003;198:1951-7.

    Not in our library10.1084/jem.20030896

45. 45.

    Lohr J, Knoechel B, Wang JJ, Villarino AV, Abbas AK. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med. 2006;203:2785-91.

    Not in our library10.1084/jem.20061341

46. 46.

    Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, et al. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol. 2007;178:6730-3.

    Not in our library10.4049/jimmunol.178.11.6730

47. 47.

    Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science. 2007;317:256-60.

    Not in our library10.1126/science.1145697

48. 48.

    Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T cells induce CD4+CD25–Foxp3– T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-β. J Immunol. 2007;178:6725-9.

    Not in our library10.4049/jimmunol.178.11.6725

49. 49.

    Page G, Sattler A, Kersten S, Thiel A, Radbruch A, Miossec P. Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression. Am J Pathol. 2004;164:409-17.

    Not in our library10.1016/s0002-9440(10)63131-8

50. 50.

    Aarvak T, Chabaud M, Miossec P, Natvig JB. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol. 1999;162:1246-51.

    Not in our library

51. 51.

    Chabaud M, Page G, Miossec P. Enhancing effect of IL-1, IL-17, and TNF-α on macrophage inflammatory protein-3α production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol. 2001;167:6015-20.

    Not in our library10.4049/jimmunol.167.10.6015

52. 52.

    Matsui T, Akahoshi T, Namai R, Hashimoto A, Kurihara Y, et al. Selective recruitment of CCR6-expressing cells by increased production of MIP-3α in rheumatoid arthritis. Clin Exp Immunol. 2001;125:155-61.

    Not in our library10.1046/j.1365-2249.2001.01542.x

Cited by papers we hold 11

• Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments · 2022
  No notice
• Intranuclear Delivery of HIF-1α-TMD Alleviates EAE via Functional Conversion of TH17 Cells · 2021
  Not checked
• Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches · 2021
  No notice
• Osteoporosis: Pathophysiology and therapeutic options · 2020
  No notice
• The Immunoregulation of Th17 in Host against Intracellular Bacterial Infection · 2018
  Not checked
• Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis · 2017
  No notice
• The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases · 2015
  No notice
• T cell migration in rheumatoid arthritis · 2015
  No notice
• Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction · 2014
  No notice
• Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors · 2010
  No notice
• Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis · 2010
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.